comparemela.com

Latest Breaking News On - Precision medicine approach - Page 1 : comparemela.com

Precision Medicine Approach Reverses Early-Stage Dementia

/PRNewswire/ Amid repeated failures of drug trials for Alzheimer s disease, a small pilot study using a precision medicine approach has reported the first.

Blood Stream Infection Is Projected To Drive Demand For Implantable Pump Catheter Market, Says Fact

Pulmonary Hypertension Emerging as a Global Health IssuePulmonary hypertension is a rapidly growing issue, especially among elderly population and in countries with the rise in aging population. The increasing pervasiveness of Pulmonary Arterial Hypertension (PAH) and a growing number of cases globally are driving d.

Trial First to Show Improvements in Alzheimer s Patients

Trial First to Show Improvements in Alzheimer s Patients News provided by Share this article Share this article BURLINGAME, Calif., May 13, 2021 /PRNewswire/ Pharmaceutical trials for Alzheimer s have failed repeatedly, but a new study, using a fundamentally different approach, has provided the first success: using precision medicine to identify and target the drivers of Alzheimer s or pre-Alzheimer s in each patient, a team of physicians and researchers has posted exciting, positive results in medRxiv, the Yale-backed site for health sciences. (PRNewsfoto/Apollo Health) (PRNewsfoto/Apollo Health) Until now, therapeutic development for Alzheimer s disease has been almost uniformly unsuccessful, with over 400 failed clinical trials. The few successes (e.g., memantine) have not offered sustained improvement. For example, the recent claim of a positive trial for the drug candidate donanemab did not show cognitive improvement, nor even stabilization of dementia, but merely red

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.